Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence



Similar documents
Rare Thoracic Tumours

بسم هللا الرحمن الرحيم

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Update on Mesothelioma

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Biphasic pericardial and pleural mesothelioma in a cat: a case report

Health effects of occupational exposure to asbestos dust

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Workers' Compensation in Japan

Male. Female. Death rates from lung cancer in USA

PLEURAL MESOTHELIOMA

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Appendix I SACCHARIN ANIMAL TEST DATA INTRODUCTION

How To Defend The Mesothelioma Case

What is Mesothelioma?

Mesothelioma: Questions and Answers

Lessons learned from the Western Australian experience with mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

Primary -Benign - Malignant Secondary

Asbestos and the diseases it causes

BE.104 Spring Evaluating Environmental Causes of Mesothelioma J. L. Sherley

THE TIMES OF OCCURRENCE OF MESOTHELIOMAS IN RATS FOLLOWING INOCULATION WITH ASBESTOS

BIOBANK LPCE-NICE CHEST

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

Sir William Osler: Listen to the patient; the patient tells you everything.

Malignant Mesothelioma in Urban Dogs

Summary of treatment benefits

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

An Introduction to Anatomy and Physiology

PROTOCOL OF THE RITA DATA QUALITY STUDY

Lung cancer and asbestos

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

INFLAMMATORY PLEURAL EFFUSION

Mesothelioma incidence modeling and forecasting

Can Amphibole Fibers/Particles Contribute to Mesothelioma and Other Asbestos Related Diseases in Northeast Minnesota?

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

ASBESTOS DISEASES. Dr Alastair Robertson

Asbestos related health risks

Sternotomy and removal of the tumor

Uses and Abuses of Pathology in Asbestos-exposed Populations

NISG Asbestos. Caroline Kirton

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

Thoracoscopy in Pleural Malignant Mesothelioma

Pathologist s Discussion of Plaintiffs Latest Theories

Columbia University Mesothelioma Applied Research Foundation Mesothelioma Center

Peritoneal Carcinosis

Omental mesothelioma as a diagnostic and therapeutic challenge: A case report

Original studies/studi originali General topics/argomenti generali

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

ALTHOUGH excellent accounts have been published in recent years of

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

An Autopsy Case of Primary Pericardial Mesothelioma in Arc Cutter Exposed to Asbestos through Talc Pencils

Determination of Asbestos Exposure by Pathology and Clinical History

Understanding Pleural Mesothelioma

MESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC

Post-Mortem Diagnosis of a Rare Biphasic Benign Multicystic Peritoneal Mesothelioma in an Indian Domestic Fowl (Gallus Domesticus)

How To Understand How Cancer Works

Malignant Mesothelioma

Recommendations for the Reporting of Pleural Mesothelioma

Malignant Mesothelioma

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge

Asbestos Related Diseases

Occupational Lung Disease. SS Visser Internal Medicine UP

Thoracic Cavity. Photo: This normal canine lung collapsed when the thorax was opened and the negative pressure was lost in the thorax.

Asbestos-Related Lung Cancer and Malignant Mesothelioma of the Pleura: Selected Current Issues

Workers around the world who encounter hazardous substances are aware of the measures needed

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Introduction to A&P (Chapter 1) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College. Eastern Campus

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson

BIOBANK LPCE-NICE CHEST

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

Epidemiology of Malignant Pleural Mesotheliomas in Croatia in the Period from 1989 to 1998

Asbestos related cancers

Anatomy Pleura Visceral Layer outer surface of lung Separates lobes of lung from each other Parietal Layer inner surface chest wall Pleural linings Co

Ahmed Farouk Abd El-Hafez, MD

Transcription:

ENVIRONMENTAL RESEARCH 29, 238-244 (1982) Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence CESARE MALTONI, FRANCO MINARDI, AND LEONILDO MORISI Institute oj Oncology, Bologna, Italy Received March 9, 1982 Erionite and crocidolite fibers were tested for carcinogenicity by intrapleural and intraperitoneal injection (una tantum) in 40 Sprague-Dawley rats per route for each fiber type. Pleural mesotheliomas were found in nine of ten animals that died within a year after intrapleural injection with erionite fibers. No pleural tumors were found among the animals treated at the same time and in the same way with crocidolite. Intraperitoneal injection of erionite did not produce mesotheliomas of the peritoneum, while a high incidence of these tumors was found among the animals treated by intraperitoneal injection of crocidolite. The studies are still in progresso A large, integrated project oflong-term bioassays ofdurable tibrous materials is now being carried out at the Institute of Oncology in Bologna. Among the materials being studied are asbestos of different types and origins; various types of natural (sedimentary and hydrothermal) zeolites, including erionite; several synthetic zeo!ites; and other organic, natural and man-made solid compounds, such as silica, alumina, talc, caolin, glass tibers, propylene tibers, etc. The purpose of the project is not only to identify any compounds that may be carcinogenic, but also to provide a relative risk assessment of those proving to be positive. The compounds are being tested by intraperitoneal and, in many instances, also by intrapleural and subcutaneous injection on groups of40 (20 male and 20 female) 8-week-old, Sprague-Dawley rats. Each compound is injected una tantum at a standard dose of25 mg in I mi ofh,o. Groups of20 males and 20 females, injected intraperitoneally, intrapleura1ly, and subcutaneously with I mi of H,O, serve as controls. The animals are allowed to live unti! spontaneous death. They are exam1ned and weighed every 2 weeks during the tirst year of experiment, and thereafter every 8 weeks. Ali detectable gross pathological changes are recorded during the examination. The animals, when moribund, are isolated to prevent cannibalismo A complete necropsy is performed on each animai. Histological examination is made on subcutaneous tissues at the site of injection and on the thymus, lungs,!iver, kidneys, adrenals, spleen, mesentery, gonads, uterus, and any other organ with pathological changes. Sedimentary erionite (kindly provided by Professor G. Gottardi, Institute of Minerology, University of Modena, Italy) was tested by ali three routes: i.e., by intraperitoneal, intrapleural, and subcutaneous injections. The studies with this 0013-93511821050238 07$02.00/0 Copyright 1982 by Aeadcmie Press,!ne. All rishts oc rcproduction in any Corm rcserved. 238

PLEURAL MESOTHELIOMAS BY ERIONITE 239 FIG. L Pleural mesothelioma ftom erionite: tubular pattern. H.-E., x 190. FIG. 2. Pleural mesothelioma ftom erionite: tubular pattern. Hyaluronic acid is present in the lumina of several tubuli. H.-E., x 190,

240 MALTONI, MINARDI, AND MORISI Fro. 3. Pleural mesotheliorna from erionite: papillary pattern. H.-E., x 122. -~ FIG. 4. Groups of mesothelioma cells, with papiilary arrangement. in pleural effusion. H.-E., x 190.

PLEURAL MESOTHELIOMAS BY ERIONITE #' 241 lttem. H.-E., X122... FIG. 5. Pleural mesothelioma from erionite: epithe1ium-like pattem. H.-E., XI90. -_.. in pleuraleffusion. H.-E., x 190. FIG. 6. Pleural mesothelioma from erionite: spindle-cellular pattem. H.-E., x 190.

242 MALTONI, MINARDI, AND MORISI FIG. 8. Deposit of erionite within a pleural mesothelioma. H.-E., X190.

SI PLEURAL MESOTHELIOMAS BY ERIONITE 243 TABLE l PLEURAL MESQTHELIOMAS IN SPRAGUE-DAWLEY RATS FOLLQWING LOCAL INJECT~ON OF ERIONITE (RESULTS AFTER 53 WEEKS) Animals Tumors at the site of injection Route of No. at No.of Pleural Peritoneai Compound administration Sex 5tart survivors mesotheliomas mesotheliomas Erionite Pleural M 20 13 6' O F 20 17 3' O M + F 40 30 9 O Peritoneal M 20 18 O O F 20 20 O O M + F 40 38 O O Crocidolite Pleural M 20 19 O O F 20 18 O O M+F 40 37 O O Peritoneal M 20 11 O 9 F 20 17 O 3 M + F 40 28 O 12 None Pleural M 20 19 O O (H,O) F 20 20 O O M+F 40 39 O O M 20 20 O O Peritoneal F 20 20 O O M+F 40 40 O O (I Latency time: 32, 47, 48, 52, and 53 (2) weeks. b Latency time: 47,52, and 53 weeks.,elioma. H.-E., x190. mineral were initiated 53 weeks ago. Results ofthe first year ofthe experiments by the intraperitoneal and intrapleural routes are reported here. Erionite has been suspected of contributing to, or being the single causative agent involved in, pleural mesotheliomas found in residents of Turkey (Baris et al., 1979). Among the 40 rats treated by intrapleural injection of erionite, lo animals died within 53 weeks, 9 with pleural mesotheliomas. Upon gross examination, the visceral, parietal, and diaphragmatic pleura appeared thickened and whitish. Moreover, several hard, whitish or yellowish nodules, from 2 to lo mm in diameter, were found scattered at different sites ofthe serosal surface. Mediastinal nodes were swollen and lungs were atelectatic. Microscopically, the mesotheliomas are polymorphous with several or ali of the following characteristics: tubular, papillary, epithelial like (solid), and spindlecellular (Figs. 1-7). The tumors, with a spotty or continuous distribution, line the pulmonary and parietal pleura and the pericardium, invade the lungs and the thoracic costai muscies, and metastasize to mediastinal nodes. Deposites of erionite suitounded by granulomatous reaction are seen within the neoplastic tissue (Fig. 8). The results of the bioassays of erionite are shown in Table 1, together with the

244 MALTONI, MINARDI, ANO MORISI results of the bioassays of crocidolite (VICC sample) (positive controls) in the same animai system, performed within the same project, at the same time. The spontaneous incidence of mesotheliomas in om breed of Sprague-Dawley rats is very low. or 2381 untreated animals kept alive until spontaneous death and periodically inspected and histopathologically examined, ollly l pleural mesothelioma was found among 1202 females, and l pericardial and 3 peritoneal mesotheliomas among 1179 males. In our experimental system, erionite appears at present to be a potent direct carcinogen for pleura, more effective than crocidolite. Moreover, our resuus suggest a different degree ofresponsiveness ofpleura and peritoneum to erionite and crocidolite. Otber natura! zeolites tested concurrently, in the same way, bave failed to sbow oncogenic effects at the site of injection after 53 weeks. REFERENCES Baris, Y. I., Artvinli, M., and Sahin, A. A. (1979). Environmental mesothelioma in Turkey. In "Health Hazards of Asbestos Exposure" (L J. Selikoff and E. C. Rammond, Eds.), Annals of the New York Academy of Sciences, VoL 330, pp. 423-432.